Trial NCT03606174

View at ClinicalTrials.gov 
Org. Study IDs: 516-003

Last trial update was posted on 2023-08-24

MeSH Interventions

Nivolumab Pembrolizumab

MeSH Conditions

Carcinoma Carcinoma, Transitional Cell Urinary Bladder Neoplasms

Other Conditions

Urothelial Carcinoma Urothelial Carcinoma Bladder Urothelial Carcinoma Ureter Urothelial Carcinoma Urethra Urothelial Carcinoma of the Renal Pelvis and Ureter

Stopping Reasons

The study was terminated due to sponsor decision / portfolio prioritization, and not due to safety reasons.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID